Literature DB >> 27470486

Incidence rate of amyloidosis in patients from a medical care program in Buenos Aires, Argentina: a prospective cohort.

María Adela Aguirre1, Bruno Rafael Boietti1, Elsa Nucifora1, Patricia Beatriz Sorroche1, Fernán González Bernaldo de Quirós1, Diego Hernan Giunta1, María Lourdes Posadas-Martínez1.   

Abstract

BACKGROUND: There are limited data concerning the incidence density (ID) of ATTRwt, AL and AA amyloidosis in the Argentinean population. Our aim was to estimate the ID of ATTRwt, AL and AA amyloidosis at the Hospital Italiano Medical Care Program in Buenos Aires, Argentina.
METHODS: Population was all members of a hospital-based health maintenance organization who were affiliated since January 2006 to December 2014. Each person was followed contributing time at risk since January 2006 or enrollment date to the final date. Incident cases of amyloidosis were captured from the institutional registry of amyloidosis. Incidence rate was calculated with 95% confidence intervals.
RESULTS: During the nine-year study period, there were 15 patients with ATTRwt, 12 with AL and 2 with AA amyloidosis for 1 105 152 person-years of follow-up. The crude ID of ATTRwt amyloidosis was 13.5 (95%CI 8.1-22.4), that of AL amyloidosis 11 (95%CI: 6-19) and that of AA amyloidosis 1.8 (95%CI: 0.5-7.2) per 1 000 000 person-years. The highest ID was found in men (31.7 for ATTRwt, 15.9 for AL and 2.27 for AA amyloidosis per 1 000 000 person-years). The ID adjusted to the population of the city of Buenos Aires was 6.46 (95%CI: 3.17-9.74) for ATTRwt, 6.13 (95%CI: 2.57-9.7) for AL and 1.21 (95%CI: 0.56 to 2.99) for AA amyloidosis.
CONCLUSIONS: This is the first paper to report the incidence density of ATTRwt, AL and AA amyloidosis in Latin America. Our results are consistent with other studies from other regions. Although systemic amyloidosis is a rare disease, it is a major health problem because of its morbi-mortality.

Entities:  

Keywords:  AA amyloidosis; AL amyloidosis; ATTRwt amyloidosis; Incidence; incidence density; systemic amyloidosis

Mesh:

Year:  2016        PMID: 27470486     DOI: 10.1080/13506129.2016.1207626

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  11 in total

1.  Incidence of AL Amyloidosis in Olmsted County, Minnesota, 1990 through 2015.

Authors:  Robert A Kyle; Dirk R Larson; Paul J Kurtin; Shaji Kumar; James R Cerhan; Terry M Therneau; S Vincent Rajkumar; Celine M Vachon; Angela Dispenzieri
Journal:  Mayo Clin Proc       Date:  2019-01-31       Impact factor: 7.616

Review 2.  Gastrointestinal Amyloidosis: Review of the Literature.

Authors:  Kyle Rowe; Jon Pankow; Fredy Nehme; William Salyers
Journal:  Cureus       Date:  2017-05-08

3.  Case report and review of the literature of primary gastrointestinal amyloidosis diagnosed with enteroscopy and endoscopic ultrasonography.

Authors:  Yi-Pin Liu; Wei-Wei Jiang; Guo-Xun Chen; Yan-Qing Li
Journal:  World J Clin Cases       Date:  2018-09-06       Impact factor: 1.337

4.  Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis.

Authors:  Vikram J Premkumar; Suzanne Lentzsch; Samuel Pan; Divaya Bhutani; Joshua Richter; Sundar Jagannath; Michaela Liedtke; Arnaud Jaccard; Ashutosh D Wechalekar; Raymond Comenzo; Vaishali Sanchorawala; Bruno Royer; Michael Rosenzweig; Jason Valent; Stefan Schönland; Rafael Fonseca; Sandy Wong; Prashant Kapoor
Journal:  Blood Cancer J       Date:  2021-01-11       Impact factor: 11.037

5.  Transdisciplinarity in the approach to amyloidosis.

Authors:  Amalia Ernestina Alfonsín; Sofia Stephanie Escada; Dana Kohan; Melina Paula Valeo Chulvi; María Lourdes Posadas Martínez; María Adela Aguirre; Elsa Mercedes Nucifora
Journal:  Rev Fac Cien Med Univ Nac Cordoba       Date:  2021-09-18

6.  Epidemiology of variant transthyretin amyloidosis at a reference center in Argentina.

Authors:  Maria S Saez; Maria A Aguirre; Diego Pérez de Arenaza; Patricia Sorroche; Elsa Nucifora; Maria L Posadas Martinez
Journal:  Mol Genet Genomic Med       Date:  2021-10-20       Impact factor: 2.183

7.  A Case of Systemic AL Amyloidosis Diagnosed by Screening Colonoscopy.

Authors:  Lynna Alnimer; Ali Zakaria; Jalpa Patel; Yazan Samhouri; Samira Ahsan; Lyle Goldman; Serge Sorser
Journal:  Case Rep Gastrointest Med       Date:  2022-04-20

8.  Global epidemiology of amyloid light-chain amyloidosis.

Authors:  Nishant Kumar; Nicole J Zhang; Dasha Cherepanov; Dorothy Romanus; Michael Hughes; Douglas V Faller
Journal:  Orphanet J Rare Dis       Date:  2022-07-19       Impact factor: 4.303

9.  Features and evolution of patients with systemic amyloidosis and cardiac involvement

Authors:  Marcelina Carretero; Ma A Aguirre; Eugenia Villanueva; Elsa Nucifora; Ma Lourdes Posadas-Martínez
Journal:  Arch Cardiol Mex       Date:  2022-01-03

10.  Clinical Practice Guidelines for diagnosis of amyloidosis: Part 1/3 Year 2020

Authors:  Maria Lourdes Posadas Martinez; María Adela Aguirre; Cesar Belziti; Eva Brouet; Miguel Angel Auteri; Ana Luz Forte; Gustavo Greloni; Sebastian Marciano; Maria Dolores Matoso; Diego Perez de Arenaza; Ariel Edgardo Pitzus; Marcelo Rugiero; Soledad Saez; Patricia Sorroche; Mauricio Tomei; Bettina Zinser; Veronica Peuchot; Elsa Nucifora
Journal:  Rev Fac Cien Med Univ Nac Cordoba       Date:  2021-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.